CRIO Continues Record Growth for 2021 as Customers Recognize Value and Efficiency Gains of eSource

CRIO, a Boston-based technology firm streamlining clinical trials for sponsors, sites and patients, announced a fifth consecutive year of record contract bookings and revenue for 2021.

Highlights for CRIO’s breakthrough 2021 include:

Record YTD contract bookings and revenue – bookings up 80% year over year
Over 300 new sites, including 5 of the top 10 research site networks
Six new sponsor clients, including three new EDC integrations
Launch of new eSource/ EDC product
Launch of eSource integration to EDC
5 straight years of revenue and customer growth
Global site network adoption of nearly 1000 across 15 countries
Doubled employee growth to 45

“The benefits of our eSource offering have really hit home in the life science and CRO industry,” said Raymond Nomizu, CEO, CRIO. “We have seen growth in all of our market segments including clinical research sites, sponsors and CROs. Our eSource solutions enable us to streamline clinical research, bringing new medications to market faster for pharma and biotechs.”

CRIO has established itself as the highest quality and most cost-effective partner for clinical trial data capture. Our eSource products allow sites to enter data once into our eSource system and then allows this data to be shared with the appropriate downstream constituents (Data Managers, Monitors, Medical Reviewers, etc.) without having to re-enter the data into EDC.

“We have created a holistic paperless platform for conducting clinical trials that will reduce data errors, streamline regulatory workflows and accelerate timelines” said Stephen Boccardo, SVP, CRIO.

With plans to integrate EMR and eConsent into eSource in 2022, CRIO will be an all-in-one platform for real-time clinical trial data capture by investigators. Enabling sites, sponsors and CROs to have direct access to clinical data captured in real-time will drive significant efficiencies in the industry and serve as the foundation for supporting decentralized clinical trials (DCT).

About CRIO

Innovation is at the heart of everything we do. Our mission is to streamline clinical research to bring new medications to market faster. We have created a holistic paperless platform for conducting clinical trials that will reduce data errors, streamline regulatory workflows and accelerate timelines. Today, CRIO supports nearly 1000 medical research sites worldwide.

For more information about CRIO, visit clinicalresearch.io

Media Contact:
Stephen Boccardo, Sr. VP Sales
(857) 957-5376
stephen.boccardo@clinicalresearch.io

CRIO Bugathon – Building the Ultimate Platform

While bugs are as natural in coding as they are in nature, we don’t want them creeping into our code. At CRIO, we have established various processes and procedures to handle bugs. At the close of 2022, we hosted a Bugathon, part of our ongoing efforts to deliver best-in-class quality. The Bugathon was a two...

CRIO Welcomes Dr. Margaretta Nyilas to its Board of Directors

BOSTON, MA – November 3, 2022 – CRIO, the industry’s leading eSource provider, announces the appointment of Dr. Margaretta Nyilas to its Board of Directors, effective immediately. Dr. Nyilas is a biopharmaceutical executive with over twenty years of diverse global industry experience, formerly at Otsuka Pharmaceuticals, Bristol Myers Squibb and Click Therapeutics. She has a...

3 Reasons to Visit CRIO at SCRS 2022

SCRS 2022 starts next week. Here are 3 reasons to stop by Booth 401 and meet Team CRIO. We’ll see you there! Friday, Oct.7 at 10:30 am. Master Workshop #1 : How the World’s Leading Vaccine Network Reduced Protocol Deviations by 40% 2. Meet the team behind the industry’s leading site-based eSource technology. CRIO delivers...